To analyze the reactivation of IRX1 expression in lung cancer cell lines, we treated A427 and A549 cells with an inhibitor of DNMT (Aza/5-Aza-2′-deoxytidine) and an inhibitor of HDAC (TSA/trichostatin A) (Figure 5c). This evidence concerns the gene IRX1 and lung cancer.